[PDF][PDF] Low-density lipoproteins cause atherosclerotic cardiovascular disease: pathophysiological, genetic, and therapeutic insights: a consensus statement from the …
OP-EHEA191011_online 2313..2340 Page 1 Low-density lipoproteins cause atherosclerotic
cardiovascular disease: pathophysiological, genetic, and therapeutic insights: a consensus …
cardiovascular disease: pathophysiological, genetic, and therapeutic insights: a consensus …
[HTML][HTML] COVID-19 in immunocompromised patients: a systematic review of cancer, hematopoietic cell and solid organ transplant patients
Background The clinical impact of severe coronavirus disease 2019 (COVID-19), caused by
severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), in immunocompromised …
severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), in immunocompromised …
Hematopoietic cell transplantation and cellular therapy survey of the EBMT: monitoring of activities and trends over 30 years
JR Passweg, H Baldomero, C Chabannon… - Bone marrow …, 2021 - nature.com
Numbers of Hematopoietic cell transplantation (HCT) in Europe and collaborating countries
continues to rise with 48,512 HCT in 43,581 patients, comprising of 19,798 (41%) allogeneic …
continues to rise with 48,512 HCT in 43,581 patients, comprising of 19,798 (41%) allogeneic …
Gene therapy using haematopoietic stem and progenitor cells
G Ferrari, AJ Thrasher, A Aiuti - Nature Reviews Genetics, 2021 - nature.com
Haematopoietic stem and progenitor cell (HSPC) gene therapy has emerged as an effective
treatment modality for monogenic disorders of the blood system such as primary …
treatment modality for monogenic disorders of the blood system such as primary …
Biomaterials for in situ cell therapy
Cell therapy has revolutionized the treatment of various diseases, such as cancers, genetic
disorders, and autoimmune diseases. Currently, most cell therapy products rely on ex vivo …
disorders, and autoimmune diseases. Currently, most cell therapy products rely on ex vivo …
Polymerization‐mediated multifunctionalization of living cells for enhanced cell‐based therapy
Surface decoration of living cells by exogenous substances offers a unique tool for
understanding and tuning cell behaviors, which plays a critical role in cell‐based therapy …
understanding and tuning cell behaviors, which plays a critical role in cell‐based therapy …
The EBMT activity survey on hematopoietic-cell transplantation and cellular therapy 2018: CAR-T's come into focus
JR Passweg, H Baldomero, C Chabannon… - Bone marrow …, 2020 - nature.com
Hematopoietic-cell transplantation (HCT) is widely used for acquired and congenital
disorders of the hematopoietic system. Number of transplants performed in Europe and …
disorders of the hematopoietic system. Number of transplants performed in Europe and …
Aptamer-functionalized exosomes from bone marrow stromal cells target bone to promote bone regeneration
ZW Luo, YW Liu, SS Rao, H Yin, J Huang, CY Chen… - Nanoscale, 2019 - pubs.rsc.org
In elderly people particularly in postmenopausal women, inadequate bone formation by
osteoblasts originating from bone marrow mesenchymal stem cells (BMSCs) for …
osteoblasts originating from bone marrow mesenchymal stem cells (BMSCs) for …
Cell therapies in the clinic
Cell therapies have emerged as a promising therapeutic modality with the potential to treat
and even cure a diverse array of diseases. Cell therapies offer unique clinical and …
and even cure a diverse array of diseases. Cell therapies offer unique clinical and …
Haematopoietic stem cell self-renewal in vivo and ex vivo
AC Wilkinson, KJ Igarashi, H Nakauchi - Nature Reviews Genetics, 2020 - nature.com
The self-renewal capacity of multipotent haematopoietic stem cells (HSCs) supports blood
system homeostasis throughout life and underlies the curative capacity of clinical HSC …
system homeostasis throughout life and underlies the curative capacity of clinical HSC …